Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Robinhood Markets heads into its July 29 earnings report with two narratives running in opposite directions — one driven by the most bullish analyst setup in the market, the other by a CEO who sold aggressively into the rally.
The short interest picture has quietly shifted. Bears have rebuilt positions over the past month, with short interest climbing to 5.1% of the free float — up roughly 6% from 30 days ago, and nudging higher again this week by about 1%. That's not an extreme level, but the direction matters: shorts have been adding consistently since mid-June, coinciding almost precisely with the stock's 34% one-month surge. The borrow market, however, offers shorts no friction to worry about. Availability is deep — over 1,100% of short interest — meaning there are roughly eleven shares available to borrow for every one already lent out. Cost to borrow is negligible at 0.48%. Shorts are building, but they're doing so cheaply and freely. Options sentiment is equally calm: the put/call ratio at 0.63 is right on top of its 20-day average, with a z-score close to zero. Neither options traders nor the borrow market are signalling stress in either direction.
The Street is a different story entirely. The analyst recommendation differential ranks in the 99th percentile — as one-sided a consensus view as you'll find anywhere. Targets have moved up at virtually every firm that touched the name in the past fortnight. Barclays lifted to $122 from $82. Morgan Stanley raised to $124 from $95, even while staying at Equal-Weight. Goldman's Buy carries a $121 target. Mizuho is the most constructive at $130. The consensus mean of $117 now sits just above the current price of $111.97, which means the Street's collective target has been swallowed by the rally. On valuation, the trailing P/E has expanded to 45x — up more than 11 points over the past 30 days — and price-to-book has moved to 9.6x. Bulls point to AI-driven product expansion, the Trump Accounts initiative, and partnerships with BNY and TradePMR as evidence the platform is evolving beyond a trading app. Bears flag that the valuation now prices in substantial execution, and that regulatory risk hasn't disappeared just because sentiment improved.
The insider data adds a layer of tension the analyst upgrades don't explain away. CEO Vladimir Tenev sold over 356,000 shares on July 6 across multiple tranches priced between $113 and $118 — totalling roughly $41 million in a single day. Chief Legal Officer Daniel Gallagher also sold that day, in smaller volume. The 90-day net insider position is technically positive at around 739,000 shares, but that figure is flattering — much of it predates the recent price surge, and the July 6 selling cluster represents some of the most concentrated insider supply the stock has seen at these price levels. Tenev remains a top-5 holder with 54.5 million shares, so these are scale-management sales rather than a vote of no confidence, but the timing — into a 33% monthly move — is hard to ignore. BlackRock added modestly in the most recent period, providing some institutional ballast.
Among closely correlated peers, COIN and ETOR both fell roughly 3-4% on the week while IBKR edged up 3%. HOOD itself is down just 0.7% on the week, which is relative resilience — but the previous two earnings prints delivered single-day moves of -8.7% and -15.2% respectively. The July 29 report is where the analyst consensus, the insider selling, and the rebuilding short base will all be stress-tested at once.
See the live data behind this article on ORTEX.
Open HOOD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
